Otsuka Pharmaceutical and H. Lundbeck’s Abilify Maintena (aripiprazole) was approved by the U.S. FDA for the maintenance monotherapy treatment of bipolar I disorder in adults.
Razorfish Health, a uniquely integrated health and wellness advertising agency, announced the promotion of Keri Hettel to SVP, Analytics and Strategy, and Brandon Ashcraft to SVP, Operations.
The health marketing and commercialization agency continues focus on growing healthcare commercialization practice and introducing more innovative business models to industry.
Takeda and BioSurfaces announced a deal to initiate a research program designed to develop innovative medical devices to treat patients with GI diseases.
Discovery Worldwide, a healthcare communications agency that combines the power of science, storytelling and innovative delivery to move health forward, announces the appointment of Rico Ricketson as Head of Client Services.
Pfizer Inc. today announced that the REFLECTIONS B7391003 study — a comparative, confirmatory safety and efficacy study of PF-06439535 versus Avastin (bevacizumab) — met its primary objective. PF-06439535 is being developed by Pfizer as a potential biosimilar to Avastin.
Bristol-Myers Squibb Company today announced that the U.S. Food and Drug Administration expanded the indication for Yervoy (ipilimumab) injection for intravenous use to now include the treatment of unresectable or metastatic melanoma in pediatric patients 12 years of age and older.
Discovery Worldwide, a healthcare communications agency that combines the power of science, storytelling and innovative delivery to move health forward, announced the appointment of Rico Ricketson as Head of Client Services.
Klick Health announced it is expanding its Behavioral Science team as part of its extensive lineup of in-house, full-service healthcare marketing and commercialization capabilities.
The Medical Advertising Hall of Fame will be holding its first Midwest event on Sept. 21, 2017, at the offices of the Sandbox Agency in Chicago.
